AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
Express News | Abbvie Inc - Skyrizi Achieves Primary and Secondary Endpoints in Phase 3 Trials
Express News | Abbvie Announces European Commission Approval of Skyrizi® (Risankizumab) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis
Express News | Abbvie : Piper Sandler Raises Target Price to $196 From $190
Express News | Abbvie : Truist Securities Raises Target Price to $210 From $195
Health Care Down as Eli Lilly Slides -- Health Care Roundup
Why AbbVie Stock Was Cruising Higher on Thursday
Piper Sandler Adjusts Price Target on AbbVie to $196 From $190
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
AbbVie on Track for Record High Close -- Data Talk
Top Midday Stories: US Advance Q2 GDP Rises; Initial Jobless Claims Drop; Ford Earnings Fall; TotalEnergies' Lower Results; AbbVie Raises Guidance; IBM, ServiceNow Report Higher Results
New Drug Sales Lift AbbVie Shares -- WSJ
Express News | AbbVie Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its 2024 Guidance
AbbVie Hits All-time High
Express News | Abbvie Shares Hit Record High, Last up 4.4%
Express News | Abbvie Exec Says Business Development Efforts Continue to Be Focused on Early Stage Assets That Can Drive Growth in the Next Decade - Conf. Call
Express News | Abbvie Exec Says Expect Rinvoq Total Revenue of About $5.7 Billion This Year, up by $100 Million From Earlier - Conf. Call
Express News | Abbvie Shares Reverse Course in Early Trading, Last up 1.9%
Express News | Abbvie Exec Says Co Expects to Maintain Parity Access Next Year for Humira for "a Meaningful Portion of Lives" Across All of the Channels - Conf. Call
Express News | AbbVie Exec Announces Discontinuation Of Further Development Of Experimental Alzheimer's Drug ABBV-916 As Standalone Antibody